C. Eide

发表

3D Printed Functional and Biological Materials on Moving Freeform Surfaces

Michael C. McAlpine, Jakub Tolar, J. Tolar, 2018, Advanced materials.

Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa

J. Wagner, J. Tolar, J. McGrath, 2013, The Journal of investigative dermatology.

Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome).

Beau R. Webber, G. Daley, M. Kyba, 2011, Blood.

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

J Wagner, J. Wagner, C. Eide, 2002, Blood.

TCIRG1 Transgenic Rescue of Osteoclast Function Using Induced Pluripotent Stem Cells Derived from Patients with Infantile Malignant Autosomal Recessive Osteopetrosis.

J. Tolar, C. Eide, Weili Chen, 2019, The Journal of bone and joint surgery. American volume.

CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation

J. Wagner, C. Eide, D. Weisdorf, 2013, Leukemia.

ABCB5+ dermal mesenchymal stromal cells with favorable skin homing and local immunomodulation for recessive dystrophic epidermolysis bullosa treatment

J. Tolar, C. Ebens, C. Eide, 2021, Stem cells.

Impaired Mitochondrial and Metabolic Function of Fibroblasts Derived from Patients with Recessive Dystrophic and Junctional Epidermolysis Bullosa

J. Tolar, C. Eide, P. Crawford, 2020, EMJ Dermatology.

Accumulation of senescence observed in spinocerebellar ataxia type 7 mouse model

H. Orr, J. Tolar, D. Seelig, 2022, PloS one.

Allotransplantation of Culture-Isolated Neonatal Rat Islet Tissue: Absence of MHC Class II Positive Antigen-Presenting Cells in Nonimmunogenic Islets

C. Eide, R. M. Meloche, O. Hegre, 1989, Diabetes.

A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells.

C. Eide, B. Blazar, D. Vallera, 1995, Blood.

Rapid generation of Col7a1−/− mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells

Beau R. Webber, J. Tolar, B. Moriarity, 2017, Laboratory Investigation.

Semi-dominant GPNMB mutations in amyloidosis cutis dyschromica.

M. Simpson, J. Tolar, J. McGrath, 2019, The Journal of investigative dermatology.

Disruption of HIV-1 Co-Receptors CCR5 and CXCR4 in Primary Human T Cells and Hematopoietic Stem and Progenitor Cells Using Base Editing.

David R. Liu, Gregory A. Newby, Anton P. McCaffrey, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

Rapid Induction of Cerebral Organoids From Human Induced Pluripotent Stem Cells Using a Chemically Defined Hydrogel and Defined Cell Culture Medium

Carolyn M. Scott, S. Keirstead, J. Dutton, 2016, Stem cells translational medicine.

A multitask clustering approach for single-cell RNA-seq analysis in Recessive Dystrophic Epidermolysis Bullosa

John R. Garbe, Rui Kuang, Huanan Zhang, 2018, PLoS Comput. Biol..

Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.

J. Wagner, J. Tolar, A. Hovnanian, 2011, The Journal of investigative dermatology.

moiety of the T-cell receptor chain Fv fusion immunotoxin specifically targeting the CD3 epsilon Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single-

C. Eide, B. Blazar, R. Kreitman, 2013 .

Anti-Graft-Versus-Host Disease Effect of DT 390-Anti-CD 3 sFv , a Single-Chain Fv Fusion Immunotoxin Specifically Targeting the CD 3 e Moiety of the T-cell Receptor

C. Eide, R. Kreitman, Daniel, 2002 .

Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single-chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor.

C. Eide, B. Blazar, D. Vallera, 1996, Blood.

Somatic mosaicism in Fanconi anemia: Evidence of genotypic reversion in lymphohematopoietic stem cells

J. Wagner, S. Batish, A. Auerbach, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Mesenchymal stromal cells in wound healing applications: role of the secretome, targeted delivery and impact on recessive dystrophic epidermolysis bullosa treatment.

J. Tolar, C. Ebens, C. Eide, 2021, Cytotherapy.

Interrogation of RDEB epidermal allografts after BMT reveals co-expression of collagen VII and keratin 15 with proinflammatory immune cells and fibroblasts.

J. Tolar, C. Ebens, C. Eide, 2022, The Journal of investigative dermatology.

CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa

Beau R. Webber, J. Tolar, C. Eide, 2016, npj Regenerative Medicine.

Base editor correction of COL7A1 in recessive dystrophic epidermolysis bullosa patient-derived fibroblasts and iPSCs.

David R. Liu, Gregory A. Newby, Beau R. Webber, 2020, Journal of Investigative Dermatology.

Future applications of 3D bioprinting: A promising technology for treating recessive dystrophic epidermolysis bullosa

J. Tolar, C. Eide, W. C. Miller, 2021, Experimental dermatology.

CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression

Beau R. Webber, J. Tolar, C. Eide, 2018, International journal of molecular sciences.

Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa

J. Tolar, D. Keene, C. Eide, 2019, The British journal of dermatology.

Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo.

J. Tolar, C. Eide, R. Negrin, 2022, Blood.